Stereotaxis Corp - STXS Short-Term Debt to Capital

STXS (Stereotaxis, Inc.) - company brandmark

This chart of Stereotaxis, Inc. (STXS) price action demonstrates the dynamics of an asset with a market value of 0.04. Stereotaxis, Inc. (STXS) dominates the magnetic catheter guidance segment, ensuring safety for both surgeons and patients. Business efficiency is supported by an extensive network of component suppliers, while outsourcing assembly to specialized third-party facilities allows the company to focus on software development.

STXS - Stereotaxis Inc Short-Term Debt to Equity Ratio over the range 07/04/2022 - 10/30/2026
Brand item of Stereotaxis

Professional managers utilize fundamental metrics to assess the stability of a balance sheet structure. This indicator measures the proportion of short-term borrowings relative to equity, determining liquidity risk when settling obligations due within one year. For Stereotaxis, Inc. (STXS), this is critical, as the development of complex cardio-robots requires massive expenditures on highly qualified engineering personnel. Analyzing the ratio of current liabilities due within one year to equity allows for an assessment of the company's financial flexibility.

Main competitors

Short-Term Debt to Equity Boston Scientific Inc (BSX)|EW: Current Liabilities to Equity|Short-Term Debt to Capital RMD (ResMed Inc.)|insulet.com (PODD) - Current Liabilities to Capital|Zimmer Biomet Holdings - Short-Term Debt to Capital|The Cooper Companies, Inc. (COO) - Short-Term Debt to Equity Ratio|ALGN: Short-Term Debt to Capital|GMED - Short-Term Debt to Capital Coefficient|TMDX (TransMedics Group Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital atecspine.com|Short-Term Debt to Equity Artivion (AORT)|Short-Term Debt to Equity ENOV (Enovis Corp)|Short-Term Debt to Capital IART (Integra)|Short-Term Debt to Capital Coefficient Establishment Labs Inc (ESTA)|BBNX: Short-Term Debt to Equity Ratio|Current Liabilities to Equity IRMD|EMBC: Short-Term Debt to Capital|Current Liabilities to Capital Tandem Diabetes Care Inc (TNDM)|AXGN (Axogen Corp) - Short-Term Debt to Capital|Short-Term Debt to Capital Ratio SIBN (SI-BONE Medical)|Short-Term Debt to Equity Ratio OFIX (Orthofix Medical Inc.)|BVS (bioventus.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity OrthoPediatrics KIDS|TMCI - Short-Term Debt to Equity Ratio|Strata Critical Medical Corp - Short-Term Debt to Capital|Current Liabilities to Capital Carlsmed Medical|RXST: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio CLPT|STIM (Neuronetics) - Short-Term Debt to Capital|Sight Sciences Inc. (SGHT) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital OBIO|Short-Term Debt to Equity Ratio anikatherapeutics.com ANIK|Short-Term Debt to Capital NSPR (InspireMD, Inc.)|Short-Term Debt to Capital Jin Medical International Ltd. ZJYL|VANI - Short-Term Debt to Equity|XTNT: Short-Term Debt to Equity|NMTC (NeuroOne Corp) - Short-Term Debt to Equity Ratio|Modular Medical, Inc. - Ratio of Short-Term Indebtedness to Capital|MYO (Myomo, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital envoymedical.com COCH|Short-Term Debt to Equity Vivos Therapeutics, Inc. (VVOS)|enVVeno Medical Corporation (NVNO) - Short-Term Indebtedness to Equity|Sintx Technologies, Inc. - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Tenon Medical Inc TNON|ReWalk Robotics Ltd. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Autonomix Medical, Inc. AMIX|INVO Fertility (IVF) - Short-Term Debt to Equity|Current Liabilities to Equity BBLG (Bone Biologics Corp.)|Short-Term Debt to Equity Axonics Modulation Technologies|Short-Term Debt to Equity Ratio Biolase Inc. (BIOL)|Short-Term Debt to Capital DYNT|FNA - Current Liabilities to Capital|Short-Term Debt to Equity INVO Bioscience INVO